AR121151A1 - FORMULATIONS FOR VACCINE AGAINST CORONAVIRUS - Google Patents

FORMULATIONS FOR VACCINE AGAINST CORONAVIRUS

Info

Publication number
AR121151A1
AR121151A1 ARP210100201A ARP210100201A AR121151A1 AR 121151 A1 AR121151 A1 AR 121151A1 AR P210100201 A ARP210100201 A AR P210100201A AR P210100201 A ARP210100201 A AR P210100201A AR 121151 A1 AR121151 A1 AR 121151A1
Authority
AR
Argentina
Prior art keywords
formulations
nanoparticles
vaccine against
against coronavirus
vaccines
Prior art date
Application number
ARP210100201A
Other languages
Spanish (es)
Inventor
Gale Smith
Michael J Massare
Jing-Hui Tian
Original Assignee
Novavax Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novavax Inc filed Critical Novavax Inc
Publication of AR121151A1 publication Critical patent/AR121151A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

En el presente documento se divulgan proteínas de la espícula (S) de coronavirus y nanopartículas que las comprenden, que son adecuadas para su uso en vacunas. Las nanopartículas presentan antígenos de patógenos rodeados y asociados con un centro detergente, que da como resultado una estabilidad potenciada y buena inmunogenia. También se divulgan dosificaciones, formulaciones, y métodos para preparar las vacunas y nanopartículas.Disclosed herein are coronavirus spike (S) proteins and nanoparticles comprising them, which are suitable for use in vaccines. The nanoparticles present pathogen antigens surrounded and associated with a detergent center, resulting in enhanced stability and good immunogenicity. Dosages, formulations, and methods for preparing the vaccines and nanoparticles are also disclosed.

ARP210100201A 2020-01-27 2021-01-27 FORMULATIONS FOR VACCINE AGAINST CORONAVIRUS AR121151A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202062966271P 2020-01-27 2020-01-27

Publications (1)

Publication Number Publication Date
AR121151A1 true AR121151A1 (en) 2022-04-20

Family

ID=81345140

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210100201A AR121151A1 (en) 2020-01-27 2021-01-27 FORMULATIONS FOR VACCINE AGAINST CORONAVIRUS

Country Status (1)

Country Link
AR (1) AR121151A1 (en)

Similar Documents

Publication Publication Date Title
MX2022009167A (en) Coronavirus vaccine formulations.
BR112018004242A2 (en) vaccine compositions having increased stability and immunogenicity
CY1121211T1 (en) HERPITAS VIRUS VACCINE
CO2020011914A2 (en) Self-Assembling Nanostructure Vaccines
CO2019002955A2 (en) Pneumococcal multivalent vaccine compositions comprising polysaccharide and protein conjugates
MX2023011163A (en) Coronavirus vaccine formulations.
CR10559A (en) INFLUENZA VACCINE
UY37811A (en) AN IMMUNOGENIC COMPOSITION THAT HAS IMPROVED STABILITY, POTENTIAL IMMUNOGENICITY AND REDUCED REACTOGENICITY AND PROCESS FOR THE PREPARATION OF THE SAME
AR092896A1 (en) IMMUNOGENIC COMPOSITIONS
AR052625A1 (en) NEW COMPOSITION
ECSP22072586A (en) VACCINE AGAINST SARS-CoV-2 VIRUS WITH CpG ADJUVANT
AR011216A1 (en) A VACCINE BASED ON SURFACE ANTIGENS AGAINST INFLUENZA, A METHOD FOR PREPARING IT, AND A METHOD FOR PREPARING SURFACE ANTIGEN PROTEINS FROM PROPAGATED INFLUENZA VIRUSES ON AN ANIMAL CELL CULTURE
CL2015001900A1 (en) Vaccines with higher density of carbohydrate antigen and new saponin adjuvant.
CY1120430T1 (en) RECOMMENDED CDV COMPOSITIONS AND USES OF THESE
BR112015022582A2 (en) nucleic acid molecule, plasmid, vaccine, and use of a plasmid
CO2022012272A2 (en) Vaccines against coronavirus and methods of use
WO2010044919A3 (en) Smallpox dna vaccine and the antigens therein that elicit an immune response
AR089995A1 (en) ROTAVIRUS SUBUNITIES VACCINES, METHODS OF PREPARATION AND USE OF THE SAME
MX2023000663A (en) Immunogenic constructs, compositions, and methods for inducing immune response.
AR121151A1 (en) FORMULATIONS FOR VACCINE AGAINST CORONAVIRUS
BR112022020298A2 (en) VACCINES, ADJUVANTS AND METHODS TO GENERATE AN IMMUNE RESPONSE
AR117191A1 (en) IMMUNOGENIC COMPOSITIONS
AR127816A1 (en) CORONAVIRUS VACCINE FORMULATIONS
BRPI0811459A8 (en) VIROSOMIC PREPARATION, USE OF A VIROSOMAL PREPARATION, KIT, AND METHODS TO VACCINATE A HUMAN AGAINST INFLUENZA INFECTIONS, AND TO VACCINATE INDIVIDUALS MAMMALIANS AGAINST INFLUENZA INFECTIONS
CO6150186A2 (en) VACCINE COMPOSITION AND IMMUNIZATION METHOD